Company intelligence / Profile preview

Alzheimer's Research and Treatment Center

Wellington, Florida, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

The ARTC has participated in and led over 400 clinical trials related to the treatment and prevention of Alzheimer's disease. The center is currently enrolling patients in numerous clinical trials for disease modification and for the first time, true prevention trials seeking to intervene before symptoms begin[3][6].

Therapeutic areas: Neurology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateBiologicDeviceVaccine
Industry: Academic Hospital/University/Research

Partnerships

EisaiMultiple pharmaceutical sponsors (not individually disclosed)National Institutes of Health (NIH)

Beyond the preview

Go deeper on Alzheimer's Research and Treatment Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alzheimer's Research and Treatment Center.

Explore the full profile